Kawasaki disease is an acute febrile illness of unknown cause that primarily affects children younger than 5 years of age.
The clinical trial “KD-CAAP” studies the effectiveness of adding a new element to the standard treatment for this disease. What are the hopes for Kawasaki disease treatment and patients?
Listen to our podcast with Prof. Paul Brogan, joined chief investigator of the KD-CAAP trial, that will explain you what Kawasaki disease is, why KD-CAAP trial is important, and what are the perspectives around this disease that affects mostly children.